Passage Bio Stock Investor Sentiment
| PASG Stock | USD 0.27 0.03 10.00% |
Roughly 65% of Passage Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Passage Bio suggests that many traders are alarmed. The current market sentiment, together with Passage Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Passage Bio stock news signals to limit their universe of possible portfolio assets.
Passage Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Passage Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Passage Bio's Stock prices. Below is the latest headlines and news related to Passage Bio Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Passage Bio that are available to investors today. This information is accessible both publicly - through Passage Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Passage-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Passage Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Passage Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Passage Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Passage Bio alpha.
Passage Largest EPS Surprises
Earnings surprises can significantly impact Passage Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-12 | 2025-03-31 | -0.2233 | -0.25 | -0.0267 | 11 | ||
2024-08-08 | 2024-06-30 | -0.31 | -0.26 | 0.05 | 16 | ||
2024-05-14 | 2024-03-31 | -0.36 | -0.3 | 0.06 | 16 | ||
2024-03-04 | 2023-12-31 | -0.4 | -0.3 | 0.1 | 25 | ||
2022-08-04 | 2022-06-30 | -0.83 | -0.73 | 0.1 | 12 | ||
2022-05-16 | 2022-03-31 | -0.89 | -0.79 | 0.1 | 11 |
There is far too much social signal, news, headlines, and media speculation about Passage Bio that are available to investors today. This information is accessible both publicly - through Passage Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Passage-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Passage Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Passage Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Passage Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Passage Bio alpha.
Passage Bio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent ... | 03/04/2025 |
2 | Passage Bio Upgraded to Buy Heres What You Should Know | 03/07/2025 |
3 | Acquisition by Cale Edgar B. of 278386 shares of Passage Bio at 0.387 subject to Rule 16b-3 | 03/14/2025 |
4 | Disposition of 75007 shares by Orbimed Advisors Llc of Passage Bio at 0.68 subject to Rule 16b-3 | 03/19/2025 |
5 | Disposition of 10326 shares by Orbimed Advisors Llc of Passage Bio at 0.38 subject to Rule 16b-3 | 04/15/2025 |
6 | Disposition of 61638 shares by Orbimed Advisors Llc of Passage Bio at 0.33 subject to Rule 16b-3 | 04/16/2025 |
7 | Disposition of 77090 shares by Orbimed Advisors Llc of Passage Bio at 0.33 subject to Rule 16b-3 | 04/17/2025 |
8 | Disposition of 78049 shares by Orbimed Advisors Llc of Passage Bio at 0.34 subject to Rule 16b-3 | 04/22/2025 |
9 | Disposition of 89328 shares by Orbimed Advisors Llc of Passage Bio at 0.34 subject to Rule 16b-3 | 04/23/2025 |
10 | Disposition of 68195 shares by Orbimed Advisors Llc of Passage Bio at 0.32 subject to Rule 16b-3 | 04/24/2025 |
11 | Orbimed Advisors LLC Reduces Stake in Passage Bio Inc A Strategic Portfolio Adjustment - GuruFocus | 04/30/2025 |
12 | Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights | 05/13/2025 |
Complementary Tools for Passage Stock analysis
When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |